Improving Patient Safety with Unique Device Identification
May 23, 2013 11:35 am | by Warren Ward-Stacey, Sales Director, PRISYM ID | Blogs | CommentsMedical device manufacturers should welcome the proposed ruling for Unique Device Identification (UDI); however, being compliant by the effective date (based on classification) for some organizations may be a concern. UDI aims to identify errors involving medical devices and provide more rapid resolution of device problems.
New Imaging Techniques Used to Help Patients Suffering from Epilepsy
May 23, 2013 11:00 am | by Canadian Association for Neuroscience | News | CommentsNew techniques in imaging of brain activity developed by Jean Gotman and his colleagues lead to improved treatment of patients suffering from epilepsy. The combination of electroencephalogram and functional magnetic resonance imaging leads to more precise localization of the areas generating epileptic seizures, giving neurosurgeons a better understanding of the optimal ways of intervention, if appropriate.
CT Detects Twice as Many Lung Cancers as X-Ray at Initial Screening Exam
May 23, 2013 10:46 am | by American College of Radiology | News | CommentsNational Lung Screening Trial investigators also conclude that the 20 percent reduction in lung cancer mortality with low-dose computed tomography versus chest X-ray screening previously reported in the NLST primary paper is achievable at experienced screening centers in the United States.
UBC Engineer Helps Pioneer Flat Spray-On Optical Lens
May 23, 2013 10:43 am | by University of British Columbia | News | CommentsA University of British Columbia engineer and a team of U.S. researchers have made a breakthrough utilizing spray-on technology that could revolutionize the way optical lenses are made and used. Kenneth Chau, an assistant professor in the School of Engineering at UBC's Okanagan campus, is a key investigator among colleagues at the National Institute of Standards and Technology in Maryland.
Doctors Save Boy by 'Printing' an Airway Tube
May 23, 2013 10:12 am | by Marilynn Marchione, AP Chief Medical Writer | News | CommentsIn a medical first, doctors used plastic particles and a 3D laser printer to create an airway splint to save the life of a baby boy who used to stop breathing nearly every day. It's the latest advance from the booming field of regenerative medicine, making body parts in the lab.
Medtronic Completes Enrollment in Landmark U.S. Study of Symplicity Renal Denervation System for Treatment-Resistant Hypertension
May 23, 2013 6:06 am | by The Associated Press | News | CommentsMedtronic, Inc., today announced it has finished randomizing Symplicity HTN-3, the company's pivotal U.S. clinical trial of the Symplicity renal denervation system for treatment-resistant hypertension. Renal denervation is a minimally invasive, catheter-based procedure to reduce activity of the renal (kidney) nerves, which are part of the sympathetic nervous system and help regulate blood pressure.
InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group
May 23, 2013 6:00 am | by PR Newswire | News | CommentsInspireMD, Inc., the leader in embolic protection stents, today announced new 6-month results from the MASTER (MGuard for Acute ST Elevation Reperfusion) trial demonstrating that the MGuard Embolic Protection Stent (EPS) outperformed bare metal and drug eluting stents in all-cause mortality in ST segment elevation myocardial infarction (STEMI) patients.
Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013
May 23, 2013 4:30 am | by PR Newswire | News | CommentsSAN DIEGO and PARIS, May 23, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced preliminary...
One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology
May 23, 2013 4:15 am | by The Associated Press | News | CommentsST. PAUL, Minn. & PARIS--(BUSINESS WIRE)--May 23, 2013--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that the company’s EnligHTN ™ Multi-Electrode Renal Denervation System provides a safe, rapid and sustained reduction in blood pressure measurements after...
New Michigan-Based Medical Product Manufacturing Effort Provides Solutions for Innovators
May 22, 2013 5:27 pm | by The Associated Press | News | CommentsThe University of Michigan Pediatric Medical Device Consortium (M-PED) is launching a new medical product manufacturing video on Vimeo. This 28-minute video: "Innovative Pediatric Manufacturing: Strategies & Solutions - A Guide To Bringing Your Device To Market" features critical...
3D PRINTING WITH FDM: How it Works
May 22, 2013 3:13 pm | by Stratasys | White PapersA 3D printer is a machine that creates objects from plastic or other materials using an additive manufacturing process. Additive manufacturing produces objects in a succession of layers from the bottom, up. This is the opposite of traditional subtractive manufacturing processes, which produce objects by cutting material away from a block to create the shape desired.
Silicon Nitride: A Next Generation Spinal Implant Material (Q&A)
May 22, 2013 2:55 pm | by Sean Fenske, Editor-in-Chief, MDT | Blogs | CommentsEric Olson is the chief executive officer and president of Amedica, the only company that produces medical grade Silicon Nitride. He took a moment to participate in the following Q&A about the unique material and its impact in medical devices, specifically in the orthopedic implant area.
Cognoptix Test Identifies Alzheimer’s Disease via Beta Amyloid Signature in the Eyes in Proof-of-Concept Clinical Trial
May 22, 2013 12:53 pm | by The Associated Press | News | CommentsACTON, Mass.--(BUSINESS WIRE)--May 22, 2013--Cognoptix, an emerging medical device company, announced today that its SAPPHIRE II eye test identified Alzheimer’s disease patients via a beta amyloid (“Ab”) signature in their eyes in a 10-subject proof-of-concept clinical trial.
New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System
May 22, 2013 12:20 pm | by PR Newswire | News | CommentsPARIS, May 22, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today reported interim data from the REDUCE-HTN clinical program, which demonstrated a significant and sustained reduction in the blood pressure of patients treated with the Vessix™ Renal Denervation...
Is There Finally A Way To Stop Severe Excessive Sweating?
May 22, 2013 12:00 pm | by PR Newswire | News | CommentsNEW YORK, May 22, 2013 /PRNewswire/ -- For the 3% of the population that suffer from hyperhidrosis, their severely excessive sweating is often embarrassing, uncomfortable, anxiety-inducing and disabling. While more than half of these people are never diagnosed or treated...



